The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo

This publication has 23 references indexed in Scilit:

• Synthesis, Storage, and Release of Vascular Endothelial Growth Factor/Vascular Permeability Factor (VEGF/VPF) by Human Mast Cells: Implications for the Biological Significance of VEGF₂₀₆
  Molecular Biology of the Cell, 1998
• Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.
  Journal of Clinical Investigation, 1997
• Expression of Biologically Active Isoforms of the Tumor Angiogenesis Factor VEGF inEscherichia coli
  Biochemical and Biophysical Research Communications, 1996
• The Carboxyl-terminal Domain(111–165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency
  Journal of Biological Chemistry, 1996
• Enhancement of Tumor Growth and Vascular Density by Transfection of Vascular Endothelial Cell Growth Factor Into MCF-7 Human Breast Carcinoma Cells
  JNCI Journal of the National Cancer Institute, 1995
• Nuclear accumulation of interferon gamma.
  Proceedings of the National Academy of Sciences, 1994
• Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.
  Journal of Clinical Investigation, 1994
• The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.
  Molecular Biology of the Cell, 1993
• Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: Identification of a class of bipartite nuclear targeting sequence
  Cell, 1991
• Subcellular fate of the lnt-2 oncoprotein is determined by choice of initiation codon
  Nature, 1990